Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;15(11):2002-2005.
doi: 10.1016/j.jcmg.2022.03.026. Epub 2022 May 11.

Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination

Manan Pareek  1 , Jeremy Steele  2 , Jeremy Asnes  3 , Lauren A Baldassarre  1 , Linda R Casale  4 , Nihar R Desai  1 , Robert W Elder  3 , Erin Faherty  2 , Ian Ferguson  5 , Robert F Fishman  4 , Zaniar Ghazizadeh  1 , Laura R Glick  1 , E Kevin Hall  2 , Rohan Khera  1 , Damianos G Kokkinidis  1 , Jennifer M Kwan  1 , Jamieson O'Marr  1 , Adam Schussheim  1 , Edward Tuohy  4 , Yanting Wang  1 , Erica S Spatz  1 , Daniel Jacoby  1 , Edward J Miller  6
Affiliations

Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination

Manan Pareek et al. JACC Cardiovasc Imaging. 2022 Nov.
No abstract available

Keywords: COVID-19; myopericarditis; vaccine.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Dr Pareek is on advisory boards for AstraZeneca and Janssen-Cilag; and has received speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, and Janssen-Cilag. Dr Khera has received support from the National Heart, Lung, and Blood Institute of the National Institutes of Health (grant K23HL153775) outside of the submitted work. Dr Miller is a consultant for Eidos, Pfizer, Siemens, Alnylam, and Roivant; and has received grant support from Eidos, Pfizer, and Argospect. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

Figure 1
Figure 1
Phase-Sensitive Inversion Recovery Images in a 19-Year-Old Man With Post–COVID-19 Vaccine Associated Myopericarditis (A to C) 4-chamber, 3-chamber, and short-axis images at the time of diagnosis demonstrating remarkable subepicardial and midmyocardial late gadolinium enhancement (LGE) along the left ventricular lateral wall (arrows). (D to F) Follow-up images 3 months after diagnosis. There is mild improvement in the 4-chamber image (D) with minimal to no improvement noted in the 3-chamber and short-axis images (E and F, arrows).
Figure 2
Figure 2
Phase-Sensitive Inversion Recovery Images in an 18-Year-Old Man With Post–COVID-19 Vaccine Associated Myopericarditis (A to C) 4-chamber, 3-chamber, and short-axis images at the time of diagnosis demonstrating subepicardial late gadolinium enhancement along the left ventricular lateral wall and mid-septal wall (arrows). (D to F) Follow-up images 6 months after diagnosis. There is notable improvement in the quantity and intensity of the late gadolinium enhancement (arrows).
See this image and copyright information in PMC

References

    1. Wise J. Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines? BMJ. 2021;373:n1635. - PubMed
    1. Montgomery J., Ryan M., Engler, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021 - PMC - PubMed

Publication types

Substances

LinkOut - more resources